“…Nearly all articles reported a higher incidence of AEFIs in females compared to males with the exception of four articles which found an opposite outcome, for most of which no clear reason could be identified other than a possible skewed distribution of the sexes and age groups in the studies ( 17 , 18 , 80 , 85 ). Of the 21 articles which reported a OR of any adverse reaction for sex, the median OR was 1.93 (range: 0.85-3.45, IQR 1.49-2.50) using males as reference group ( Supplementary Table S8 ) ( 2 , 6 , 13 , 22 , 24 , 25 , 34 , 43 , 45 – 47 , 52 , 54 , 56 , 61 , 63 , 66 , 68 , 79 , 81 , 85 ). Similarly, females had a median 1.96 times higher odds of reporting a local reaction compared to males (range: 1.02-2.90, IQR1.85-2.54) ( 22 , 32 , 42 , 54 , 76 ).…”